Incannex Healthcare Inc. (IXHL): Total Liabilities
$7.06M
As of 2025-06-30
$5.05M
As of 2026-03-31
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $7.06M | +21.1% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $5.83M | +97.1% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $2.96M | n/a | 2024-09-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $7.06M | +21.1% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
Compare IXHL, ATNM, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗